comparemela.com

Latest Breaking News On - Pharmaceuticals japan - Page 1 : comparemela.com

Transcripts For CNBC Power Lunch 20130904

Well at the moment, and in a moment Mary Thompson will join us for the nyse side of the debacle but first Bertha Coombs is live from the nasdaq. Bertha. Reporter simon, this was a bit of a sort of son of the flash freeze that we saw back on august 22nd, the nasdaq saying that, its quote system, its ss. I. P. , the system and data feed that gives out quotes, failed this morning at 11 35. They say the outage lasted six minutes and it was contained to a range of tickers. Now, the nasdaq says that this time it appears the problem was a back end server failure and that the backup system did kick in. It took about six minutes. Youll recall back on august 22nd it took about 30 minutes for them to get the system back up and running and figure out what the problem was. Back then the issue was a software glitch. A Software Problem that caused them to shut everything down on socalled tapec, the nasdaq distribution feed, so we saw a threehour halt before they finally were able to bring everyone ba

Nxera Pharma is the New Name for Sosei Group

01.04.2024 - New name expresses the Company’s vision to lead the next era of medicine - from Japan, for Japan, and by extension, to the world – and its mission to accelerate the development of life-changing medicines, by investing in science and technologySosei . Seite 1

Sosei Heptares Announces Submission of New Drug Application in Japan for Daridorexant (ACT-541468), a Dual Orexin Receptor Antagonist for the Treatment of Insomnia

Sosei Heptares Announces Submission of New Drug Application in Japan for Daridorexant (ACT-541468), a Dual Orexin Receptor Antagonist for the Treatment of Insomnia
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Sosei Heptares Announces Submission of New Drug Application in Japan for Daridorexant (ACT-541468), a Dual Orexin Receptor Antagonist for the Treatment of Insomnia

Sosei Heptares Announces Submission of New Drug Application in Japan for Daridorexant (ACT-541468), a Dual Orexin Receptor Antagonist for the Treatment of Insomnia
sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.